Sample preparation for serum/plasma profiling and biomarker identification by mass spectrometry

[1]  R. Jansen,et al.  Analysis of human serum by liquid chromatography-mass spectrometry: improved sample preparation and data analysis. , 2006, Journal of chromatography. A.

[2]  Jacques Crommen,et al.  Capillary electrophoresis‐mass spectrometry, an attractive tool for drug bioanalysis and biomarker discovery , 2006, Electrophoresis.

[3]  D. Kwong,et al.  Surface‐enhanced laser desorption/ionization time‐of‐flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma , 2006, Cancer.

[4]  Xun Qu,et al.  Biomarker discovery for ovarian cancer using SELDI-TOF-MS. , 2006, Gynecologic oncology.

[5]  A. J. Nijdam,et al.  Selective binding and enrichment for low‐molecular weight biomarker molecules in human plasma after exposure to nanoporous silica particles , 2006, Proteomics.

[6]  W. Leung,et al.  Diagnosis of gastric cancer by serum proteomic fingerprinting. , 2006, Gastroenterology.

[7]  Sen-Yung Hsieh,et al.  Systematical evaluation of the effects of sample collection procedures on low‐molecular‐weight serum/plasma proteome profiling , 2006, Proteomics.

[8]  Mauro Ferrari,et al.  Fractionation of serum components using nanoporous substrates. , 2006, Bioconjugate chemistry.

[9]  Rency S Varghese,et al.  Enrichment of low molecular weight fraction of serum for MS analysis of peptides associated with hepatocellular carcinoma , 2006, Proteomics.

[10]  Brian Leyland-Jones,et al.  A systems approach to clinical oncology: Focus on breast cancer , 2006, Proteome Science.

[11]  J. Sandoval,et al.  Neuroblastoma detection using serum proteomic profiling: a novel mining technique for cancer? , 2006, Journal of pediatric surgery.

[12]  C. Huck,et al.  Biomarker discovery in breast cancer serum using 2‐D differential gel electrophoresis/ MALDI‐TOF/TOF and data validation by routine clinical assays , 2006, Electrophoresis.

[13]  Alexandre Louvet,et al.  Mass spectrometric approach for screening modifications of total serum N-glycome in human diseases: application to cirrhosis. , 2006, Glycobiology.

[14]  Jos H Beijnen,et al.  Identification of serum proteins discriminating colorectal cancer patients and healthy controls using surface-enhanced laser desorption ionisation-time of flight mass spectrometry. , 2006, World journal of gastroenterology.

[15]  J. Sung,et al.  Serum Proteomic Fingerprints of Adult Patients with Severe Acute Respiratory Syndrome , 2006, Clinical chemistry.

[16]  D. Gozal,et al.  Serum Proteomic Patterns Associated With Sleep-Disordered Breathing in Children , 2006, Pediatric Research.

[17]  O. Dammann,et al.  Protein Detection in Dried Blood by Surface-Enhanced Laser Desorption/Ionization-Time of Flight Mass Spectrometry (SELDI-TOF MS) , 2006, Neonatology.

[18]  H. Lai,et al.  Plasma proteomic pattern as biomarkers for ovarian cancer. , 2006, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

[19]  Simon C. F. Sheng,et al.  Multidimensional Liquid Chromatography Separation of Intact Proteins by Chromatographic Focusing and Reversed Phase of the Human Serum Proteome , 2006, Molecular & Cellular Proteomics.

[20]  P. Geurts,et al.  Discovery of new rheumatoid arthritis biomarkers using the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry ProteinChip approach. , 2005, Arthritis and rheumatism.

[21]  Xin Lu,et al.  Proteomic Profiling in the Sera of Workers Occupationally Exposed to Arsenic and Lead: Identification of Potential Biomarkers , 2005, Biometals.

[22]  G. Bonn,et al.  Cu(II)-loaded iminodiacetic acid-silica particles for protein profiling of human serum samples using surface-enhanced affinity capture: support porosity effects. , 2005, Rapid communications in mass spectrometry : RCM.

[23]  Kym Faull,et al.  Characterization of serum biomarkers for detection of early stage ovarian cancer , 2005, Proteomics.

[24]  Y. Hoshida,et al.  Proteomic analysis of sera from hepatocellular carcinoma patients after radiofrequency ablation treatment , 2005, Proteomics.

[25]  Peng-Yuan Yang,et al.  Heat‐shock protein 27: A potential biomarker for hepatocellular carcinoma identified by serum proteome analysis , 2005, Proteomics.

[26]  W. Kolch,et al.  Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery. , 2005, Mass spectrometry reviews.

[27]  H. Klocker,et al.  Derivatized cellulose combined with MALDI-TOF MS: a new tool for serum protein profiling. , 2005, Journal of proteome research.

[28]  C. Shou,et al.  Preliminary study on proteomics of gastric carcinoma and its clinical significance. , 2005, World journal of gastroenterology.

[29]  W. Y. Zhang,et al.  Serum proteomic features for detection of endometrial cancer , 2005, International Journal of Gynecologic Cancer.

[30]  André M Deelder,et al.  Reliability of human serum protein profiles generated with C8 magnetic beads assisted MALDI-TOF mass spectrometry. , 2005, Analytical chemistry.

[31]  A. Puisieux,et al.  Protein chip array profiling analysis of sera from neuroblastoma patients. , 2005, Cancer letters.

[32]  P. Limbach,et al.  Serum protein profiling using surfactant-aided matrix-assisted laser desorption/ionization mass spectrometry , 2005 .

[33]  David A Bennett,et al.  High-resolution serum proteomic profiling of Alzheimer disease samples reveals disease-specific, carrier-protein-bound mass signatures. , 2005, Clinical chemistry.

[34]  A. Ganser,et al.  Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis , 2005, Expert review of proteomics.

[35]  R. Townsend,et al.  Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. , 2005, Clinical chemistry.

[36]  Tesshi Yamada,et al.  Identification of 2 serum biomarkers of renal cell carcinoma by surface enhanced laser desorption/ionization mass spectrometry. , 2005, The Journal of urology.

[37]  A. Rustgi,et al.  Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry. , 2005, Journal of proteome research.

[38]  Victor G Zgoda,et al.  Ovarian cancer marker of 11.7 kDa detected by proteomics is a serum amyloid A1 , 2005, Proteomics.

[39]  S. Tannenbaum,et al.  Comparative plasma proteome analysis of lymphoma-bearing SJL mice. , 2005, Journal of proteome research.

[40]  J. Barrett,et al.  Influences of blood sample processing on low-molecular-weight proteome identified by surface-enhanced laser desorption/ionization mass spectrometry. , 2005, Clinical chemistry.

[41]  C. Koebnick,et al.  Influence of hormone replacement therapy on proteomic pattern in serum of postmenopausal women. , 2005, Maturitas.

[42]  Shu-hua Chen,et al.  Nanoprobe-based affinity mass spectrometry for selected protein profiling in human plasma. , 2005, Analytical chemistry.

[43]  E. Marchiori,et al.  Sample handling for mass spectrometric proteomic investigations of human sera. , 2005, Analytical chemistry.

[44]  Shu Zheng,et al.  Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma. , 2005, Chinese medical journal.

[45]  Min-Seok Kwon,et al.  Efficient prefractionation of low‐abundance proteins in human plasma and construction of a two‐dimensional map , 2005, Proteomics.

[46]  H. Tammen,et al.  Peptidomic analysis of human blood specimens: Comparison between plasma specimens and serum by differential peptide display , 2005, Proteomics.

[47]  O John Semmes,et al.  Analysis of Human Proteome Organization Plasma Proteome Project (HUPO PPP) reference specimens using surface enhanced laser desorption/ionization‐time of flight (SELDI‐TOF) mass spectrometry: Multi‐institution correlation of spectra and identification of biomarkers , 2005, Proteomics.

[48]  I. Dryden,et al.  Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[49]  Hong Wang,et al.  A wide range of protein isoforms in serum and plasma uncovered by a quantitative intact protein analysis system , 2005, Proteomics.

[50]  Jiekai Yu,et al.  SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer. , 2005, Breast.

[51]  D. Herold,et al.  Immunoaffinity separation of plasma proteins by IgY microbeads: Meeting the needs of proteomic sample preparation and analysis , 2005, Proteomics.

[52]  D. Speicher,et al.  Depletion of multiple high‐abundance proteins improves protein profiling capacities of human serum and plasma , 2005, Proteomics.

[53]  Graham B. I. Scott,et al.  HUPO Plasma Proteome Project specimen collection and handling: Towards the standardization of parameters for plasma proteome samples , 2005, Proteomics.

[54]  W. Barrett,et al.  Differences among techniques for high‐abundant protein depletion , 2005, Proteomics.

[55]  T. Veenstra,et al.  Quantitative analysis of the low molecular weight serum proteome using 18O stable isotope labeling in a lung tumor xenograft mouse model , 2005, Journal of the American Society for Mass Spectrometry.

[56]  J. Richie,et al.  Chromatofocusing fractionation and two‐dimensional difference gel electrophoresis for low abundance serum proteins , 2005, Proteomics.

[57]  T. Veenstra,et al.  Investigation of the mouse serum proteome. , 2005, Journal of proteome research.

[58]  Wei Zhang,et al.  Application of serum SELDI proteomic patterns in diagnosis of lung cancer , 2005, BMC Cancer.

[59]  E. Kohn,et al.  Ovarian cancer in the proteomics era: diagnosis, prognosis, and therapeutics targets , 2005, International Journal of Gynecologic Cancer.

[60]  Xiao-Ying Meng,et al.  Classification of cancer types by measuring variants of host response proteins using SELDI serum assays , 2005, International journal of cancer.

[61]  J. Casal,et al.  Proteomic expression analysis of colorectal cancer by two‐dimensional differential gel electrophoresis , 2005, Proteomics.

[62]  Harald Mischak,et al.  Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes , 2005, Electrophoresis.

[63]  W. Vach,et al.  Serum protein profiling by miniaturized solid-phase extraction and matrix-assisted laser desorption/ionization mass spectrometry. , 2005, Rapid communications in mass spectrometry : RCM.

[64]  K. Baggerly,et al.  Diagnostic protein discovery using liquid chromatography/mass spectrometry for proteolytic peptide targeting. , 2005, Rapid communications in mass spectrometry : RCM.

[65]  B. Hitt,et al.  Low molecular weight proteomic information distinguishes metastatic from benign pheochromocytoma. , 2005, Endocrine-related cancer.

[66]  S. Baumann,et al.  Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. , 2005, Clinical chemistry.

[67]  T. K. Hayes,et al.  Rarity gives a charm: evaluation of trace proteins in plasma and serum , 2005, Expert review of proteomics.

[68]  R. Morris,et al.  Evaluation of biomarker discovery approaches to detect protein biomarkers of acute renal allograft rejection. , 2005, Journal of proteome research.

[69]  K. Coombes,et al.  Direct tandem mass spectrometry reveals limitations in protein profiling experiments for plasma biomarker discovery. , 2005, Journal of proteome research.

[70]  L. Lomas,et al.  A simplified monobuffer multidimensional chromatography for high-throughput proteome fractionation. , 2005, Journal of chromatography. A.

[71]  Jakob Bunkenborg,et al.  A Proteomic Analysis of Human Hemodialysis Fluid*S , 2005, Molecular & Cellular Proteomics.

[72]  J. Moul,et al.  Proteomics in prostate cancer , 2005, Current opinion in urology.

[73]  P. Tempst,et al.  Correcting common errors in identifying cancer-specific serum peptide signatures. , 2005, Journal of proteome research.

[74]  S. Flibotte,et al.  Identification of serum amyloid A as a biomarker to distinguish prostate cancer patients with bone lesions. , 2005, Clinical chemistry.

[75]  Weijian Guo,et al.  Prediction of Pancreatic Cancer by Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classification , 2005, Oncology.

[76]  H. Bitter,et al.  An automated, sheathless capillary electrophoresis‐mass spectrometry platform for discovery of biomarkers in human serum , 2005, Electrophoresis.

[77]  Philippe Marin,et al.  Proteomic detection of prostate-specific antigen using a serum fractionation procedure: potential implication for new low-abundance cancer biomarkers detection. , 2005, Analytical biochemistry.

[78]  S. Egawa,et al.  High molecular mass proteome of androgen‐independent prostate cancer , 2005, Proteomics.

[79]  O John Semmes,et al.  SELDI‐TOF MS profiling of serum for detection of the progression of chronic hepatitis C to hepatocellular carcinoma , 2005, Hepatology.

[80]  G. Opiteck,et al.  Biomarker discovery in biological fluids. , 2005, Methods.

[81]  K. Chong-Kook,et al.  Identification of hemoglobin‐α and ‐β subunits as potential serum biomarkers for the diagnosis and prognosis of ovarian cancer , 2005, Cancer science.

[82]  J. Bergquist,et al.  Depletion of high-abundant proteins in body fluids prior to liquid chromatography fourier transform ion cyclotron resonance mass spectrometry. , 2005, Journal of proteome research.

[83]  Ronald J Moore,et al.  Comparative proteome analyses of human plasma following in vivo lipopolysaccharide administration using multidimensional separations coupled with tandem mass spectrometry , 2005, Proteomics.

[84]  William E Grizzle,et al.  Serum levels of an isoform of apolipoprotein A-II as a potential marker for prostate cancer. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[85]  Ruedi Aebersold,et al.  High Throughput Quantitative Analysis of Serum Proteins Using Glycopeptide Capture and Liquid Chromatography Mass Spectrometry *S , 2005, Molecular & Cellular Proteomics.

[86]  Ning Zhang,et al.  High Throughput Proteome Screening for Biomarker Detection* , 2005, Molecular & Cellular Proteomics.

[87]  Kevin R Coombes,et al.  Plasma protein profiling for diagnosis of pancreatic cancer reveals the presence of host response proteins. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[88]  Timothy D. Veenstra,et al.  Proteomic patterns: their potential for disease diagnosis , 2005, Molecular and Cellular Endocrinology.

[89]  S. Gammeltoft,et al.  Upregulated expression of human neutrophil peptides 1, 2 and 3 (HNP 1-3) in colon cancer serum and tumours: a biomarker study , 2005, BMC Cancer.

[90]  Walter S. Liggett,et al.  Measurement Reproducibility in the Early Stages of Biomarker Development , 2005, Disease markers.

[91]  Pierre Bedossa,et al.  Identification of a new marker of hepatocellular carcinoma by serum protein profiling of patients with chronic liver diseases , 2005, Hepatology.

[92]  Bai Xiao,et al.  Proteomic Fingerprints for Potential Application to Early Diagnosis of Severe Acute Respiratory Syndrome , 2005, Clinical chemistry.

[93]  O John Semmes,et al.  Serum, salivary and tissue proteomics for discovery of biomarkers for head and neck cancers , 2005, Expert review of molecular diagnostics.

[94]  Shu Zheng,et al.  Artificial Neural Networks Analysis of Surface-Enhanced Laser Desorption/Ionization Mass Spectra of Serum Protein Pattern Distinguishes Colorectal Cancer from Healthy Population , 2004, Clinical Cancer Research.

[95]  G. Hortin,et al.  Potential interferences from blood collection tubes in mass spectrometric analyses of serum polypeptides. , 2004, Clinical chemistry.

[96]  K. Baggerly,et al.  Diagnostic protein discovery using proteolytic peptide targeting and identification. , 2004, Rapid communications in mass spectrometry : RCM.

[97]  Yi-ding Chen,et al.  World Journal of Gastroenterology , 2022 .

[98]  Rebekah L. Gundry,et al.  Heart Disease, Clinical Proteomics and Mass Spectrometry , 2004, Disease markers.

[99]  Yongyi Mao,et al.  Informatics Platform for Global Proteomic Profiling and Biomarker Discovery Using Liquid Chromatography-Tandem Mass Spectrometry*S , 2004, Molecular & Cellular Proteomics.

[100]  Zheng Wang,et al.  Protein Chip Array Profiling Analysis in Patients with Severe Acute Respiratory Syndrome Identified Serum Amyloid A Protein as a Biomarker Potentially Useful in Monitoring the Extent of Pneumonia , 2004, Clinical chemistry.

[101]  D. Chan,et al.  Identification of tumor‐associated plasma biomarkers using proteomic techniques: From mouse to human , 2004, Proteomics.

[102]  Y. Kwak,et al.  The comparative analysis of serum proteomes for the discovery of biomarkers for acute myeloid leukemia. , 2004, Experimental hematology.

[103]  M. Deeg,et al.  Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients , 2004, Laboratory Investigation.

[104]  Eric R Siegel,et al.  Diagnosis of pancreatic cancer using serum proteomic profiling. , 2004, Neoplasia.

[105]  Julie Perkins,et al.  Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins. , 2004, Journal of proteome research.

[106]  R. Bast,et al.  Three Biomarkers Identified from Serum Proteomic Analysis for the Detection of Early Stage Ovarian Cancer , 2004, Cancer Research.

[107]  Xiaodong Zhu,et al.  New serum biomarkers for detection of HBV-induced liver cirrhosis using SELDI protein chip technology. , 2004, World journal of gastroenterology.

[108]  David C Muddiman,et al.  Analysis of the low molecular weight fraction of serum by LC-dual ESI-FT-ICR mass spectrometry: precision of retention time, mass, and ion abundance. , 2004, Analytical chemistry.

[109]  Jean-Charles Sanchez,et al.  ApoC‐I and ApoC‐III as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke , 2004, Proteomics.

[110]  J. Lapidus,et al.  Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. , 2004, JAMA.

[111]  O. John Semmes,et al.  SELDI-TOF Serum Profiling for Prognostic and Diagnostic Classification of Breast Cancers , 2004, Disease markers.

[112]  H. R. Bergen,et al.  Discovery of Ovarian Cancer Biomarkers in Serum Using NanoLC Electrospray Ionization TOF and FT-ICR Mass Spectrometry , 2004, Disease markers.

[113]  K. Rodland.  Proteomics and cancer diagnosis: the potential of mass spectrometry. , 2004, Clinical biochemistry.

[114]  H. Mischak,et al.  Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use , 2004, Electrophoresis.

[115]  G. Rice,et al.  Proteomic-based identification of haptoglobin-1 precursor as a novel circulating biomarker of ovarian cancer , 2004, British Journal of Cancer.

[116]  Erika Check,et al.  Proteomics and cancer: Running before we can walk? , 2004, Nature.

[117]  D. Morton,et al.  Detection of Differentially Expressed Proteins in Early‐Stage Melanoma Patients Using SELDI‐TOF Mass Spectrometry , 2004, Annals of the New York Academy of Sciences.

[118]  S. Boggs.  Protein profiling in respiratory disease: techniques and impact , 2004, Expert review of proteomics.

[119]  E. Petricoin,et al.  High-resolution serum proteomic features for ovarian cancer detection. , 2004, Endocrine-related cancer.

[120]  E. Diamandis.  How are we going to discover new cancer biomarkers? A proteomic approach for bladder cancer. , 2004, Clinical chemistry.

[121]  Daniel W Chan,et al.  Detection of prostate cancer using serum proteomics pattern in a histologically confirmed population. , 2004, The Journal of urology.

[122]  Timothy Planche,et al.  A novel and accurate diagnostic test for human African trypanosomiasis , 2004, The Lancet.

[123]  R. Bischoff,et al.  Methodological advances in the discovery of protein and peptide disease markers. , 2004, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[124]  T. Veenstra,et al.  Organic solvent extraction of proteins and peptides from serum as an effective sample preparation for detection and identification of biomarkers by mass spectrometry , 2004, Proteomics.

[125]  Fumio Nomura,et al.  Identification of novel and downregulated biomarkers for alcoholism by surface enhanced laser desorption/ionization‐mass spectrometry , 2004, Proteomics.

[126]  Hanno Langen,et al.  How Industry Is Approaching the Search for New Diagnostic Markers and Biomarkers* , 2004, Molecular & Cellular Proteomics.

[127]  E. Diamandis.  Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool , 2004, Molecular & Cellular Proteomics.

[128]  Usha Menon,et al.  Progress and Challenges in Screening for Early Detection of Ovarian Cancer* , 2004, Molecular & Cellular Proteomics.

[129]  T. Colgan,et al.  Protein expression profiling of endometrial malignancies reveals a new tumor marker: chaperonin 10. , 2004, Journal of proteome research.

[130]  Jeffrey S. Morris,et al.  Reproducibility of SELDI-TOF protein patterns in serum: comparing datasets from different experiments , 2004, Bioinform..

[131]  E. Diamandis.  Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems. , 2004, Journal of the National Cancer Institute.

[132]  E. Diamandis.  Re: diagnostic potential of serum proteomic patterns in prostate cancer. , 2004, The Journal of urology.

[133]  Mary Ann Comunale,et al.  Comparative proteomic analysis of de‐N‐glycosylated serum from hepatitis B carriers reveals polypeptides that correlate with disease status , 2004, Proteomics.

[134]  O John Semmes,et al.  Serum Protein Profiles to Identify Head and Neck Cancer , 2004, Clinical Cancer Research.

[135]  E. Holland,et al.  Serum peptide profiling by magnetic particle-assisted, automated sample processing and MALDI-TOF mass spectrometry. , 2004, Analytical chemistry.

[136]  E. Petricoin,et al.  SELDI-TOF-based serum proteomic pattern diagnostics for early detection of cancer. , 2004, Current opinion in biotechnology.

[137]  L. Arckens,et al.  Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics. , 2004, Current opinion in biotechnology.

[138]  Deborah Pinchev,et al.  Mining biomarkers in human sera using proteomic tools , 2004, Proteomics.

[139]  Jean-Charles Sanchez,et al.  Fatty Acid Binding Protein as a Serum Marker for the Early Diagnosis of Stroke , 2004, Molecular & Cellular Proteomics.

[140]  T. Kang,et al.  Pattern analysis of serum proteome distinguishes renal cell carcinoma from other urologic diseases and healthy persons , 2003, Proteomics.

[141]  P. Selby,et al.  Proteomic profiling of urinary proteins in renal cancer by surface enhanced laser desorption ionization and neural-network analysis: identification of key issues affecting potential clinical utility. , 2003, Cancer research.

[142]  T. Veenstra,et al.  Characterization of the Low Molecular Weight Human Serum Proteome*S , 2003, Molecular & Cellular Proteomics.

[143]  K. Kozak,et al.  Identification of biomarkers for ovarian cancer using strong anion-exchange ProteinChips: Potential use in diagnosis and prognosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[144]  R. Dwek,et al.  Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. , 2003, Glycobiology.

[145]  Bao-Ling Adam,et al.  Diagnostic potential of serum proteomic patterns in prostate cancer. , 2003, The Journal of urology.

[146]  A. Vlahou,et al.  A novel approach toward development of a rapid blood test for breast cancer. , 2003, Clinical breast cancer.

[147]  S. Gygi,et al.  Haptoglobin-α subunit as potential serum biomarker in ovarian cancer: Identification and characterization using proteomic profiling and mass spectrometry , 2003 .

[148]  E. Diamandis.  Point: Proteomic patterns in biological fluids: do they represent the future of cancer diagnostics? , 2003, Clinical chemistry.

[149]  Fang Wang,et al.  The human serum proteome: Display of nearly 3700 chromatographically separated protein spots on two‐dimensional electrophoresis gels and identification of 325 distinct proteins , 2003, Proteomics.

[150]  Min Zhan,et al.  A data review and re-assessment of ovarian cancer serum proteomic profiling , 2003, BMC Bioinformatics.

[151]  Ruedi Aebersold,et al.  Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry , 2003, Nature Biotechnology.

[152]  A. Stieg,et al.  Identification and preliminary clinical evaluation of a 50.8-kDa serum marker for prostate cancer. , 2003, Urology.

[153]  Weimin Zhu,et al.  Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. , 2003, Journal of proteome research.

[154]  Zhao Rui,et al.  Use of serological proteomic methods to find biomarkers associated with breast cancer , 2003, Proteomics.

[155]  N. Anderson,et al.  Multi‐component immunoaffinity subtraction chromatography: An innovative step towards a comprehensive survey of the human plasma proteome , 2003, Proteomics.

[156]  J. Welsh,et al.  Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[157]  K. Spencer.  The influence of different sample collection types on the levels of markers used for Down's syndrome screening as measured by the Kryptor Immunosassay system , 2003, Annals of clinical biochemistry.

[158]  J. Michalski,et al.  The effects of ethanol on the glycosylation of human transferrin. , 2003, Glycobiology.

[159]  Stephen O. David,et al.  A novel experimental design for comparative two‐dimensional gel analysis: Two‐dimensional difference gel electrophoresis incorporating a pooled internal standard , 2003, Proteomics.

[160]  E. Fung,et al.  Proteomic approaches to tumor marker discovery. , 2002, Archives of pathology & laboratory medicine.

[161]  Ronald J. Moore,et al.  Toward a Human Blood Serum Proteome , 2002, Molecular & Cellular Proteomics.

[162]  S. Lindgren,et al.  Diagnostic accuracy of alpha(1)-acid glycoprotein fucosylation for liver cirrhosis in patients undergoing hepatic biopsy. , 2002, Clinical chemistry.

[163]  N. Anderson,et al.  The Human Plasma Proteome , 2002, Molecular & Cellular Proteomics.

[164]  I. Goldstein.  Lectin structure-activity: the story is never over. , 2002, Journal of agricultural and food chemistry.

[165]  Emanuel F. Petricoin,et al.  Clinical Applications of Proteomics: Proteomic Pattern Diagnostics , 2002, Journal of Mammary Gland Biology and Neoplasia.

[166]  P. Schellhammer,et al.  Boosted decision tree analysis of surface-enhanced laser desorption/ionization mass spectral serum profiles discriminates prostate cancer from noncancer patients. , 2002, Clinical chemistry.

[167]  T. Uchida,et al.  Application of a novel protein biochip technology for detection and identification of rheumatoid arthritis biomarkers in synovial fluid. , 2002, Journal of proteome research.

[168]  D. Chan,et al.  Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer. , 2002, Clinical chemistry.

[169]  P. Schellhammer,et al.  Serum protein fingerprinting coupled with a pattern-matching algorithm distinguishes prostate cancer from benign prostate hyperplasia and healthy men. , 2002, Cancer research.

[170]  Thomas P Conrads,et al.  The SELDI-TOF MS approach to proteomics: protein profiling and biomarker identification. , 2002, Biochemical and biophysical research communications.

[171]  E. Petricoin,et al.  Use of proteomic patterns in serum to identify ovarian cancer , 2002, The Lancet.

[172]  Nan Hu,et al.  2D Differential In-gel Electrophoresis for the Identification of Esophageal Scans Cell Cancer-specific Protein Markers* , 2002, Molecular & Cellular Proteomics.

[173]  R. Linhardt,et al.  Heparin-protein interactions. , 2002, Angewandte Chemie.

[174]  D. Speicher,et al.  Comprehensive analysis of complex proteomes using microscale solution isoelectrofocusing prior to narrow pH range two‐dimensional electrophoresis , 2002, Proteomics.

[175]  G. Rice,et al.  Proteomic analysis of human plasma: Failure of centrifugal ultrafiltration to remove albumin and other high molecular weight proteins , 2001, Proteomics.

[176]  N. Brünner,et al.  Soluble Urokinase Plasminogen Activator Receptor Measurements: Influence of Sample Handling , 2001, The International journal of biological markers.

[177]  Pier Giorgio Righetti,et al.  Prefractionation techniques in proteome analysis , 2001, Proteomics.

[178]  K Chapman,et al.  The ProteinChip Biomarker System from Ciphergen Biosystems: a novel proteomics platform for rapid biomarker discovery and validation. , 2001, Biochemical Society transactions.

[179]  N Seta,et al.  Protein glycosylation and diseases: blood and urinary oligosaccharides as markers for diagnosis and therapeutic monitoring. , 2000, Clinical chemistry.

[180]  Malin M. Young,et al.  High throughput protein fold identification by using experimental constraints derived from intramolecular cross-links and mass spectrometry , 2000, Proc. Natl. Acad. Sci. USA.

[181]  S. Weinberger,et al.  Recent advancements in surface‐enhanced laser desorption/ionization‐time of flight‐mass spectrometry , 2000, Electrophoresis.

[182]  J. White.  EDTA-induced changes in platelet structure and function: clot retraction , 2000, Platelets.

[183]  R. Bast,et al.  OVX1 radioimmunoassay results are dependent on the method of sample collection and storage. , 1999, Clinical chemistry.

[184]  A. Kobata.  A retrospective and prospective view of glycopathology , 1998, Glycoconjugate Journal.

[185]  M. Sampson,et al.  Positive interference in lithium determinations from clot activator in collection container. , 1997, Clinical chemistry.

[186]  S. Hakomori.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[187]  R. Freitag,et al.  Fluorescein isothiocyanate-labeled protein G as an affinity ligand in affinity/immunocapillary electrophoresis with fluorescence detection. , 1994, Analytical chemistry.

[188]  G. Wickus,et al.  Interference in the Allégro immunoassay system when blood is collected in silicone-coated tubes. , 1992, Clinical chemistry.

[189]  R. Laessig,et al.  Comparison of plastic vs. glass evacuated serum-separator (SST) blood-drawing tubes for common clinical chemistry determinations. , 1992, Clinical chemistry.

[190]  Harold C. Mack,et al.  THE PLASMA PROTEINS , 1960 .

[191]  Bao-xue Yang,et al.  Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer. , 2006, Asian journal of andrology.

[192]  Yuquan Wei,et al.  Serum proteomics study of the squamous cell carcinoma antigen 1 in tongue cancer. , 2006, Oral oncology.

[193]  Shu Zheng,et al.  Serum protein fingerprinting coupled with artificial neural network distinguishes glioma from healthy population or brain benign tumor. , 2005, Journal of Zhejiang University. Science. B.

[194]  W. Wodzig,et al.  Protein profiling as a diagnostic tool in clinical chemistry: a review , 2005, Clinical chemistry and laboratory medicine.

[195]  P. Davidsson,et al.  Comparison of different depletion strategies for improved resolution in proteomic analysis of human serum samples , 2005, Proteomics.

[196]  T. Joos,et al.  The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets. , 2004, Trends in biotechnology.

[197]  J. Hirabayashi.  Lectin-based structural glycomics: Glycoproteomics and glycan profiling , 2004, Glycoconjugate Journal.

[198]  B. Adam,et al.  Identification of patients with head and neck cancer using serum protein profiles. , 2004, Archives of otolaryngology--head & neck surgery.

[199]  R. Pereiro.  M. D. Luque de Castro, J. L. Luque Garcia: Acceleration and Automation of Solid Sample Treatment , 2003 .

[200]  E. Høgdall,et al.  Stability of YKL-40 concentration in blood samples. , 2000, Scandinavian journal of clinical and laboratory investigation.

[201]  W. McGuire,et al.  Breast Cancer 4 , 1981, Springer US.

[202]  F. Putnam.  The plasma proteins: Structure, function, and genetic control , 1975 .